Lv7
3840 积分 2022-12-31 加入
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
5个月前
已完结
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902
5个月前
已完结
Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization
6个月前
已完结
Radiomics-based Support Vector Machine Distinguishes Molecular Events Driving Progression of Lung Adenocarcinoma
7个月前
已完结
皖公网安备34019202002308
